These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23603979)

  • 41. Curcumin ameliorates the neurodegenerative pathology in A53T α-synuclein cell model of Parkinson's disease through the downregulation of mTOR/p70S6K signaling and the recovery of macroautophagy.
    Jiang TF; Zhang YJ; Zhou HY; Wang HM; Tian LP; Liu J; Ding JQ; Chen SD
    J Neuroimmune Pharmacol; 2013 Mar; 8(1):356-69. PubMed ID: 23325107
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Caffeic acid reduces A53T α-synuclein by activating JNK/Bcl-2-mediated autophagy in vitro and improves behaviour and protects dopaminergic neurons in a mouse model of Parkinson's disease.
    Zhang Y; Wu Q; Zhang L; Wang Q; Yang Z; Liu J; Feng L
    Pharmacol Res; 2019 Dec; 150():104538. PubMed ID: 31707034
    [TBL] [Abstract][Full Text] [Related]  

  • 43. β-asarone increases MEF2D and TH levels and reduces α-synuclein level in 6-OHDA-induced rats via regulating the HSP70/MAPK/MEF2D/Beclin-1 pathway: Chaperone-mediated autophagy activation, macroautophagy inhibition and HSP70 up-expression.
    Huang L; Deng M; He Y; Lu S; Liu S; Fang Y
    Behav Brain Res; 2016 Oct; 313():370-379. PubMed ID: 27444243
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Specific Knockdown of α-Synuclein by Peptide-Directed Proteasome Degradation Rescued Its Associated Neurotoxicity.
    Qu J; Ren X; Xue F; He Y; Zhang R; Zheng Y; Huang H; Wang W; Zhang J
    Cell Chem Biol; 2020 Jun; 27(6):751-762.e4. PubMed ID: 32359427
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of α-synuclein.
    Ebrahimi-Fakhari D; Cantuti-Castelvetri I; Fan Z; Rockenstein E; Masliah E; Hyman BT; McLean PJ; Unni VK
    J Neurosci; 2011 Oct; 31(41):14508-20. PubMed ID: 21994367
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationship between alpha synuclein phosphorylation, proteasomal inhibition and cell death: relevance to Parkinson's disease pathogenesis.
    Chau KY; Ching HL; Schapira AH; Cooper JM
    J Neurochem; 2009 Aug; 110(3):1005-13. PubMed ID: 19493164
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fas-associated factor 1 induces the accumulation of α-synuclein through autophagic suppression in dopaminergic neurons.
    Kim BS; Jang T; Yoo SE; Lee JM; Kim E
    FASEB J; 2021 Apr; 35(4):e21363. PubMed ID: 33749937
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantitative Characterization of α-Synuclein Aggregation in Living Cells through Automated Microfluidics Feedback Control.
    Perrino G; Wilson C; Santorelli M; di Bernardo D
    Cell Rep; 2019 Apr; 27(3):916-927.e5. PubMed ID: 30995486
    [TBL] [Abstract][Full Text] [Related]  

  • 49. alpha-Synuclein budding yeast model: toxicity enhanced by impaired proteasome and oxidative stress.
    Sharma N; Brandis KA; Herrera SK; Johnson BE; Vaidya T; Shrestha R; Debburman SK
    J Mol Neurosci; 2006; 28(2):161-78. PubMed ID: 16679556
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lysosomal degradation of alpha-synuclein in vivo.
    Mak SK; McCormack AL; Manning-Bog AB; Cuervo AM; Di Monte DA
    J Biol Chem; 2010 Apr; 285(18):13621-9. PubMed ID: 20200163
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis.
    Tanaka Y; Engelender S; Igarashi S; Rao RK; Wanner T; Tanzi RE; Sawa A; L Dawson V; Dawson TM; Ross CA
    Hum Mol Genet; 2001 Apr; 10(9):919-26. PubMed ID: 11309365
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric alpha-synuclein.
    Yu WH; Dorado B; Figueroa HY; Wang L; Planel E; Cookson MR; Clark LN; Duff KE
    Am J Pathol; 2009 Aug; 175(2):736-47. PubMed ID: 19628769
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prolyl oligopeptidase acts as a link between chaperone-mediated autophagy and macroautophagy.
    Cui H; Norrbacka S; Myöhänen TT
    Biochem Pharmacol; 2022 Mar; 197():114899. PubMed ID: 34968496
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proteomic Study of a Parkinson's Disease Model of Undifferentiated SH-SY5Y Cells Induced by a Proteasome Inhibitor.
    Jiang H; Yu Y; Liu S; Zhu M; Dong X; Wu J; Zhang Z; Zhang M; Zhang Y
    Int J Med Sci; 2019; 16(1):84-92. PubMed ID: 30662332
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The ER retention protein RER1 promotes alpha-synuclein degradation via the proteasome.
    Park HJ; Ryu D; Parmar M; Giasson BI; McFarland NR
    PLoS One; 2017; 12(9):e0184262. PubMed ID: 28877262
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Autophagy and Alpha-Synuclein: Relevance to Parkinson's Disease and Related Synucleopathies.
    Xilouri M; Brekk OR; Stefanis L
    Mov Disord; 2016 Feb; 31(2):178-92. PubMed ID: 26813776
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Accelerated formation of alpha-synuclein oligomers by concerted action of the 20S proteasome and familial Parkinson mutations.
    Lewis KA; Yaeger A; DeMartino GN; Thomas PJ
    J Bioenerg Biomembr; 2010 Feb; 42(1):85-95. PubMed ID: 20148295
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Urate promotes SNCA/α-synuclein clearance via regulating mTOR-dependent macroautophagy.
    Sheng YL; Chen X; Hou XO; Yuan X; Yuan BS; Yuan YQ; Zhang QL; Cao X; Liu CF; Luo WF; Hu LF
    Exp Neurol; 2017 Nov; 297():138-147. PubMed ID: 28821398
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oxidative stress, induced by 6-hydroxydopamine, reduces proteasome activities in PC12 cells: implications for the pathogenesis of Parkinson's disease.
    Elkon H; Melamed E; Offen D
    J Mol Neurosci; 2004; 24(3):387-400. PubMed ID: 15655261
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Insulin-like growth factor-I mediates neuroprotection in proteasome inhibition-induced cytotoxicity in SH-SY5Y cells.
    Cheng B; Maffi SK; Martinez AA; Acosta YP; Morales LD; Roberts JL
    Mol Cell Neurosci; 2011 Jul; 47(3):181-90. PubMed ID: 21545837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.